What drugmakers should consider when accessing the Latin American market

Zulf Masters, chief executive of Masters Speciality Pharma, provides an Expert View on the challenges and opportunities of bringing medicines to Latin America.

The Latin American population has the same medical needs as patients the world over. There are those who suffer from afflictions ranging from the common cold to rare and orphan diseases.

Unfortunately, access to affordable, effective medicines for patients in developing countries has become increasingly difficult as the pharmaceutical industry evolves under the pressure of growing competition, price erosion and complex regulation.